Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042393
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2014-01-07
First Post:
2002-07-27
Brief Title:
An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Hepatitis B |
Keywords:
| Name | View |
|---|---|
| Hepatitis B Chronic | View |